Mark Greve

1.2k total citations
57 papers, 834 citations indexed

About

Mark Greve is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Mark Greve has authored 57 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Ophthalmology, 42 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Neurology. Recurrent topics in Mark Greve's work include Retinal Diseases and Treatments (29 papers), Retinal Imaging and Analysis (23 papers) and Retinal and Macular Surgery (19 papers). Mark Greve is often cited by papers focused on Retinal Diseases and Treatments (29 papers), Retinal Imaging and Analysis (23 papers) and Retinal and Macular Surgery (19 papers). Mark Greve collaborates with scholars based in Canada, United States and Italy. Mark Greve's co-authors include Matthew Tennant, Christopher J. Rudnisky, Brad J. Hinz, Alexander R. de Leon, Gholam A. Peyman, Peter J. Kertes, Geoff Williams, Tom Sheidow, Ivan Galić and Ezekiel Weis and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Mark Greve

52 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Greve Canada 17 673 593 70 67 64 57 834
Torkel Snellingen China 17 542 0.8× 328 0.6× 125 1.8× 172 2.6× 10 0.2× 30 723
Z Roth United States 11 286 0.4× 212 0.4× 75 1.1× 82 1.2× 15 0.2× 31 490
Taygan Yilmaz United States 13 369 0.5× 117 0.2× 22 0.3× 41 0.6× 22 0.3× 31 498
Suganeswari Ganesan India 14 422 0.6× 300 0.5× 109 1.6× 95 1.4× 23 0.4× 33 584
Fernando Korn Malerbi Brazil 14 313 0.5× 311 0.5× 35 0.5× 32 0.5× 10 0.2× 53 541
Eileen L. Mayro United States 11 291 0.4× 160 0.3× 25 0.4× 108 1.6× 9 0.1× 26 383
William L. Rich United States 10 406 0.6× 232 0.4× 19 0.3× 92 1.4× 19 0.3× 11 537
Kais Algawi Ireland 10 120 0.2× 183 0.3× 39 0.6× 99 1.5× 11 0.2× 17 434
Hyung Taek Lim South Korea 8 114 0.2× 95 0.2× 10 0.1× 88 1.3× 30 0.5× 8 339
Warren R. Fagadau United States 10 273 0.4× 157 0.3× 30 0.4× 68 1.0× 31 0.5× 13 385

Countries citing papers authored by Mark Greve

Since Specialization
Citations

This map shows the geographic impact of Mark Greve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Greve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Greve more than expected).

Fields of papers citing papers by Mark Greve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Greve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Greve. The network helps show where Mark Greve may publish in the future.

Co-authorship network of co-authors of Mark Greve

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Greve. A scholar is included among the top collaborators of Mark Greve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Greve. Mark Greve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alati, Caterina, Gaetana Porto, Mark Greve, et al.. (2025). SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma. Cancers. 17(21). 3471–3471.
3.
Kertes, Peter J., Tom Sheidow, Geoff Williams, et al.. (2021). Long-Term Efficacy of a Treat-and-Extend Regimen with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: An Open-Label 12-Month Extension to the CANTREAT Study. Ophthalmologica. 245(3). 230–238. 3 indexed citations
4.
Greve, Mark. (2019). Food dependent exercise induced anaphylaxis triggered by inhaled antigen. The American Journal of Emergency Medicine. 37(4). 796.e1–796.e2. 2 indexed citations
5.
Hooper, Philip L., Marie Carole Boucher, Alan F. Cruess, et al.. (2017). Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy. Canadian Journal of Ophthalmology. 52. S45–S74. 13 indexed citations
6.
Nazarali, Samir, et al.. (2017). Childhood glaucoma in neonatal Marfan syndrome resulting from a novel FBN1 deletion. Canadian Journal of Ophthalmology. 52(5). e171–e173. 7 indexed citations
7.
Spirn, Marc J., et al.. (2014). Outcomes of scleral buckle removal with and without concurrent prophylactic laser retinopexy. Canadian Journal of Ophthalmology. 49(1). 30–34. 5 indexed citations
8.
Hooper, Philip L., Kevin Colleaux, Alan F. Cruess, et al.. (2013). Contemporary Management of Diabetic Retinopathy in Canada: From Guidelines to Algorithm Guidance. Ophthalmologica. 231(1). 2–15. 8 indexed citations
9.
Cruess, Alan F., Alan R. Berger, Kevin Colleaux, et al.. (2012). Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration. Canadian Journal of Ophthalmology. 47(3). 227–235. 23 indexed citations
10.
MacDonald, Ian M., et al.. (2011). Phenotype and Genotype of Patients with Autosomal Recessive Bestrophinopathy. Ophthalmic Genetics. 33(3). 123–129. 28 indexed citations
11.
Sheidow, Tom, Philip L. Hooper, Peter J. Kertes, et al.. (2009). Combination Therapy in Neovascular Age-Related Macular Degeneration (amd): A Three-Armed, Randomized, Prospective Clinical Trial of Low Fluence Photodynamic Therapy (rpdt) With Adjunctive Avastin and Triamcinolone Acetonide (Kenalog)(Triple Therapy) versus Rpdt With Adjunctive Avastin (Double Therapy) versus Monotherapy With Avastin. Investigative Ophthalmology & Visual Science. 50(13). 1922–1922. 1 indexed citations
12.
Tennant, Matthew, et al.. (2009). Short report: suboptimal diabetes care in high‐risk diabetic patients attending a specialist retina clinic. Diabetic Medicine. 26(12). 1296–1300. 1 indexed citations
13.
Hinz, Brad J., et al.. (2006). Bilateral exudative retinal detachments as initial presentation of sympathetic ophthalmia in Turner syndrome. Canadian Journal of Ophthalmology. 41(4). 494–496. 5 indexed citations
14.
Eiberg, Jonas, Nikolaj Eldrup, Peter Qvarfordt, et al.. (2006). Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial. European Journal of Vascular and Endovascular Surgery. 32(4). 431–438. 27 indexed citations
15.
Hinz, Brad J., et al.. (2003). Current use of dietary supplementation in patients with age-related macular degeneration. Canadian Journal of Ophthalmology. 38(1). 27–32. 21 indexed citations
16.
Cui, Jing, Brad J. Hinz, Mark Greve, et al.. (2003). Expression of neuropilin-1 in choroidal neovascular membranes. Canadian Journal of Ophthalmology. 38(1). 41–45. 7 indexed citations
17.
Rudnisky, Christopher J., Brad J. Hinz, Matthew Tennant, Alexander R. de Leon, & Mark Greve. (2002). High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology. 109(2). 267–274. 71 indexed citations
18.
Tennant, Matthew, et al.. (2001). Identification of diabetic retinopathy by stereoscopic digital imaging via teleophthalmology: a comparison to slide film. Canadian Journal of Ophthalmology. 36(4). 187–196. 41 indexed citations
19.
Peyman, Gholam A., et al.. (1994). Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group.. PubMed. 29(2). 66–9. 14 indexed citations
20.
Peyman, Gholam A., et al.. (1994). The surgical management of retinopathy of prematurity using a perfluorocarbon liquid. International Ophthalmology. 18(2). 97–100. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026